We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
ES-HEALTHCARE NAV, returns and fees — Eastspring Global Healthcare Fund | Robowealth
Shows where this fund stands in its group. Not investment advice · Data as of 16 Nov 2026
NAV per unit
NAV (THB/unit) · 16 Nov 202616.7678YTD+1.7700 (+11.80%)
Risk
7
MDD
−10.4%
Dividend
None
AUM
872M
0.00%
NAV change over the selected periodN/A
Sector fundCurrency hedged 94.05%
What it invests in
Fact sheet data as of 30 Sep 2026
ES-HEALTHCARE invests through the master fund Janus Henderson Global Life Sciences Fund 97.47%
Master fund data as of 30 Sep 2026
This fund
ES-HEALTHCARE
Invests in units of another fund
→
The fund that actually invests
Janus Henderson Global Life Sciences Fund
Class I2 (USD) Acc · Luxembourg
This fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
The fund spreads its money across many companies
Top 10 companies combined 42.75% of fund value
Other stocks and cash
The fund's allocation: Eli Lilly and Co 9.37%, Johnson & Johnson 7.58%, ABBVIE 4.81%, Unitedhealth Group 4.16%, AstraZeneca 3.62%, Thermo Fisher 3.27%, Novartis 2.66%, Roche 2.61%, argenx 2.39%, Merck & 2.29%, and other stocks and cash 57.25%
Past performance is not a guarantee of future results
Go deeper
Yearly returns
Up in 6 of 10 years · best 2019 +22.87% · worst 2016 −15.79%
Monthly returns
Positive months: 81 of 137 (59%) · Best Apr 2020 +12.54% · Worst Jan 2016 −14.22%
Tap a year to see its months · * part year
Year
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2026
+0.0
+1.7
−6.7
+1.5
+1.8
+8.1
−0.8
+3.2
−4.2
+6.3
+1.2
·
2025
+5.3
−0.4
−4.8
−0.8
−6.0
+1.8
−1.2
+5.6
+2.2
+8.3
+8.8
−0.4
2024
+2.3
+3.5
+1.4
−4.9
+2.9
+2.7
+1.6
+3.9
−3.0
−3.4
−1.0
−8.0
2023
−0.3
−4.2
+1.9
+3.5
−2.7
+2.8
+0.2
−1.6
−3.9
−6.8
+6.4
+6.8
2022
−8.9
+0.2
+3.4
−6.2
−1.3
−0.7
+4.6
−3.7
−2.7
+7.8
+4.0
−1.4
2021
−0.9
+0.2
−2.4
+2.7
+0.1
+3.5
+0.3
+2.6
−3.4
+3.9
−6.9
+6.6
Average
−0.2
−0.3
−1.1
+0.9
+0.4
+2.8
+1.7
+0.4
−2.1
−0.1
+3.2
+0.1
Holding returns: worst · median · best
Every start date since 6 Jul 2015 · 3 and 6 months are total % · 1 year and over is % per year
Worst to best (green = gain, red = loss)Half of all outcomes fall in this rangeMedian
Risk
Drawdown from peak
Largest drawdown in the selected period −29.57%Previous peak 5 Aug 2015 (NAV 10.4560) → Trough 3 Nov 2016 (NAV 7.3639) · Back to the previous peak on 28 Sep 2018, after 1 year 10 months
Currently −1.57% from the peak NAV of 17.0355 (9 Nov 2026)
Change between the 2 points
Below the previous peakLargest drawdown period (previous peak → recovery)Drawdown = NAV ÷ highest prior NAV in the selected period − 1Drag across the chart to pick 2 points (on a phone, hold with 2 fingers)
Go deeper
Return vs SD
Over 1 year, ES-HEALTHCARE returned 0.88 per unit of SD, ranking 21 of 40 funds · The highest is KFHEALTH-A (1.34)
Costs
Minimum first purchase1 THB
Front-end fee1.07%
Buy cut-off time15:30
Sell cut-off time15:30
Redemption proceedsT+4
TER (actual)1.241% / yr
Go deeper
Order cut-off times
Buy15:30
Sell15:30
Purchase and redemption terms
Minimum first purchase1 THB
Minimum subsequent purchase1 THB
Minimum redemption1 THB
Minimum units per redemption1.0000
Minimum balanceNot specified
Minimum unit balanceNot specified
Redemption settlement periodT+4Business days after the order date
รายละเอียดเกี่ยวกับนโยบายการลงทุน Its largest holdings are Janus Capital Funds PLC- Global Life Sciences Fund I USD Acc (JANGLII) 97.47% (fact sheet 30 Sep 2026)
How risky is it?+−
Risk level 7 of 8 (High risk). Since 6 Jul 2015, its NAV has fallen as much as −29.57% from its peak.
What are the fees?+−
Actual total expense ratio (TER) 1.24% a year, against a ceiling of 5.35%. Management fee 1.07%. Front-end fee 1.07%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
Does it pay dividends?+−
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
What is the minimum purchase, and when do I get my money after selling?+−
Minimum first purchase 1 THB, subsequent purchases 1 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+4
Does it hedge currency risk?+−
Hedged at the manager's discretion. As of 30 Sep 2026, 94.05% of the value of its foreign investments was hedged
Warning Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Next in lineThermo Fisher Laboratory instruments 3.27%Novartis Hospitals and medical services 2.66%Roche Hospitals and medical services 2.61%argenx Vyvgart 2.39%Merck & Hospitals and medical services 2.29%
Based on the master fund's share of this fund's value (97.47% as of 30 Sep 2026) × each stock's weight in the master fund · stocks as of 30 Sep 2026 · fact sheet from Janus Henderson · Illustrations are for explanation only, not individual stock recommendations
+4.16%/yr
16.88%
−23.27%
+0.25
7Y
+63.21%+7.25%/yr
18.81%
−27.36%
+0.39
10Y
+106.70%+7.53%/yr
17.60%
−27.36%
+0.43
MAX
+67.74%+4.66%/yr
18.18%
−29.57%
+0.26
Return
MDD
SD
Return/SD
1Y
+15.55%
−10.42%
17.61%
+0.88
3Y
+42.03%+12.41%/yr
−23.27%
16.50%
+0.75
5Y
+22.62%+4.16%/yr
−23.27%
16.88%
+0.25
7Y
+63.21%+7.25%/yr
−27.36%
18.81%
+0.39
10Y
+106.70%+7.53%/yr
−27.36%
17.60%
+0.43
MAX
+67.74%+4.66%/yr
−29.57%
18.18%
+0.26
3YTop 25% of the group
Rank 10 of 37 funds
Return +12.41% per year
3Y returns of 37 funds in the Health Care group, sorted from highest to lowest. This fund ranks 10
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Only No tax benefit share classes are counted, and only funds with a full track record for the period are included · Calculated from NAV as of 16 Nov 2026